KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CHRS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Coherus BioSciences stock price up more than 5.70% on Friday
(Updated on Apr 26, 2024)

Sell candidate since Apr 23, 2024 Loss -6.42% PDF

The Coherus BioSciences stock price gained 5.70% on the last trading day (Friday, 26th Apr 2024), rising from $1.93 to $2.04. During the last trading day the stock fluctuated 6.74% from a day low at $1.93 to a day high of $2.06. The price has fallen in 5 of the last 10 days and is down by -8.52% for this period. Volume fell on the last day by -1 million shares and in total, 901 thousand shares were bought and sold for approximately $1.84 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.93 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -8.54% during the next 3 months and, with a 90% probability hold a price between $1.76 and $2.43 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CHRS Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 5.70%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Coherus BioSciences stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.06 and $2.28. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Coherus BioSciences stock

Coherus BioSciences finds support from accumulated volume at $2.02 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.130 between high and low, or 6.74%. For the last week, the stock has had daily average volatility of 7.34%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CHRS) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Coherus BioSciences to open at $2.01, and during the day (based on 14 day Average True Range), to move between $1.88 and $2.20, which gives a possible trading interval of +/-$0.158 (+/-7.72%) up or down from last closing price. If Coherus BioSciences takes out the full calculated possible swing range there will be an estimated 15.44% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.02 (0.98%) than the resistance at $2.30 (12.75%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Coherus BioSciences stock A Buy?

Coherus BioSciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -2.148 Sell Candidate Upgraded

Predicted Opening Price for Coherus BioSciences of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$2.01 ( 1.47%) $2.04

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CHRS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.14 4.90 %
R2 2.09 2.47 %
R1 2.06 0.96 %
Current price: 2.04
Support S1 1.96 -3.90 %
S2 1.93 -5.41 %
S3 1.88 -7.84 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.39 17.16 %
R2 2.32 13.73 %
R1 2.30 12.75 %
Current price 2.04
Support S1 2.02 -0.98%
S2 2.00 -1.96%
S3 1.93 -5.39%

FAQ

What is the symbol for Coherus BioSciences Stock and on which exchange is it traded?
The symbol for Coherus BioSciences is CHRS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Coherus BioSciences Stock?
Coherus BioSciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Coherus BioSciences Stock?
Coherus BioSciences Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Coherus BioSciences Stock.

What's the current price of Coherus BioSciences Stock?
As of the end of day on the Apr 26, 2024, the price of an Coherus BioSciences (CHRS) share was $2.04.

What is the 52-week high and low for Coherus BioSciences Stock?
The 52-week high for Coherus BioSciences Stock is $8.22 and the 52-week low is $1.44.

What is the market capitalization of Coherus BioSciences Stock?
As of the Apr 26, 2024, the market capitalization of Coherus BioSciences is 219.051M.

When is the next earnings date for Coherus BioSciences?
The upcoming earnings date for Coherus BioSciences is May 13, 2024.
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT